PA
RXST icon

Parallel Advisors’s RxSight RXST Stock Holding History

Parallel Advisors’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.67K Sell
346
-414
-54% -$2.5K ﹤0.01% 3563
2026
Q1 		$4.68K Sell
760
-317
-29% -$2.63K ﹤0.01% 3053
2025
Q4 		$11.2K Sell
1,077
-356
-25% -$3.57K ﹤0.01% 2559
2025
Q3 		$12.9K Buy
+1,433
New +$12.6K ﹤0.01% 2441
2025
Q2 		– Sell
-56
Closed -$1.41K – 3682
2025
Q1 		$1.41K Buy
56
+53
+1,767% +$1.57K ﹤0.01% 3057
2024
Q4 		$103 Sell
3
-6,988
-100% -$315K ﹤0.01% 3431
2024
Q3 		$346K Sell
6,991
-942
-12% -$48.3K 0.01% 708
2024
Q2 		$477K Buy
+7,933
New +$453K 0.01% 548

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
CLA
Carnegie Lake Advisors Princeton, New Jersey $268M AUM 22.32% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Parallel Advisors's RXST Position: Q2 2026 in Review

Parallel Advisors reduced its RxSight (RXST) stake by 54% in Q2 2026, selling an estimated $2.5K and leaving 346 shares worth $1.67K. The position accounts for ﹤0.01% of the portfolio, ranked #3563.

Parallel Advisors first reported a position in RXST in Q2 2024 and has held it in 8 quarters since. The position peaked at $477K in Q2 2024. 38 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Parallel Advisors held 346 shares of RxSight worth $1.67K as of Q2 2026.
  • Parallel Advisors sold 414 RxSight shares in Q2 2026, an estimated $2.5K.
  • RxSight made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #3563 holding.
  • Parallel Advisors first reported a position in RxSight in Q2 2024 and has held it in 8 quarters since.
  • Parallel Advisors's RxSight position peaked at $477K in Q2 2024.
  • 38 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.